Company intelligence / Profile preview

Vistakon

Jacksonville, Florida, United Statesjnj.com ↗

Ownership: Private
Employees: ~4200
Development stage: Commercial

Overview

Johnson & Johnson Vision Care revolutionized the vision care industry with the launch of ACUVUE®, the world’s first disposable soft contact lens in 1987. The company remains a global leader in disposable contact lenses and has expanded into surgical ophthalmology through acquisitions. Its pharmaceutical division previously marketed ophthalmic drugs but these have been discontinued or integrated into broader J&J portfolios[1][2][5].

Therapeutic areas: OphthalmologyImmunology
Modalities: DeviceSmall moleculeBiologic
Industry: Consumable Medical Devices

Drug pipeline

1 asset

ACUVUE

Commercial

Indications: Vision correction

Partnerships

BioClinica Inc. for clinical trial data management systems

Beyond the preview

Go deeper on Vistakon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vistakon.

Explore the full profile